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SHORT-term l and prolonged~-R insulin independence has been recently reponed following human islet 
allotransplantatioh in diabetic patients. indicating that it is 
possible to replace the endocrine function of the pancreas 
by an islet transplant in man. Nevenheless. rejection 
remains the major problem limiting the clinical applicabil-
ity of islet transplantation in patients with type I diabetes 
mellitus (OM). 
This repon documents our initial experience on human 
islet intrahepatic allotransplantation using FK 506 as main 
immunosuppressive agent. 
Twenty-two intrahepatic islet allografts were performed 
in 21 patients: 10 patients. aged 8 to 58 years. underwent 
combined liver-islet allotransplantation following upper-
abdominal exenteration for tumors too extensive to be 
removed with less drastic procedures.b .7 Preliminary re-
sults on these patients have been reponed previously. ~ 
Four type I diabetic patients. aged 22 to 56. years received 
a combined liver-islet allograft (the indications for liver 
transplantation were cirrhosis secondary to hepatitis C. 
alcoholic cirrhosis. and cryptogenic cirrhosis). Eight pa-
tients. aged 28 to 42 years. received nine combined cadav-
eric kidney-islet grafts (one retransplant) for end-stage 
renal disease secondary to type 10M. One patient had 
detectable c-peptide before the islet transplant and was 
excluded from analysis. 
The human islets were obtained by a modificationS of the 
automated method for human islet isolation9 and infused 
into the liver via the ponal vein. 
Immunosuppression was performed with FK 506 (clus-
ters) and FK 506 plus steroids (type 10M). Supplemen-
tary steroids or OKT3 was given if rejection was suspected 
clinically or diagnosed by biopsy. 
Six patients who received a combined liver-islet allograft 
following the cluster resection did not require insulin for 5 
to over 19 months. The first patient. who received the islet 
allograft on January 10. 1990. is still insulin independent 
over 19 months postoperatively. Since the first repon. ~ 
three patients died for cancer recurrence. 
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All patients with type I OM who received either a 
combined liver-islet or a kidney-islet allograft still require 
insulin therapy. Nevenheless. basal and stimulated c-pep-
tide production is present in all patients. and 10% to 90% 
reduction in insulin requirement has been observed. 
Our results indicate that simultaneous allotransplanta-
tion of a liver may constitute a favorable factor for islet 
allograft survival in cluster patients. Rejection is still a 
major problem in patients with type 10M. although 
adverse factors such as steroids. FK 506. and type 1 OM 
itself. may have contributed to impair islet engraftment 
and/or function in these patients. 
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